Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Nagafuchi

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Rheumatology|January 17, 2014
Comparison of phenotype and outcome in microscopic polyangiitis between Europe and JapanShunsuke Furuta, Afzal N Chaudhry, Yoshitomo Hamano, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|June 19, 2022
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccinesMariko Mouri, Mitsuru Imamura, Shotaro Suzuki, et al.
Modern Rheumatology|December 1, 2021
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitisTakahiko Sugihara, Yoshikazu Nakaoka, Haruhito A Uchida, et al.
Modern Rheumatology|June 9, 2025
Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two yearsKenji Nagasaka, Koichi Amano, Hiroko Nagafuchi, et al.
Modern Rheumatology|December 8, 2022
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 monthsKenji Nagasaka, Koichi Amano, Hiroaki Dobashi, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 11, 2024
Clinical Characteristics and Treatment Outcomes of Patients With Newly Diagnosed Takayasu Arteritis in Japan During the First 2 Years of Treatment - A Nationwide Retrospective Cohort StudyHaruhito A Uchida, Yoshikazu Nakaoka, Takahiko Sugihara, et al.
Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.
Modern Rheumatology|September 20, 2011
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV studyShoichi Ozaki, Tatsuya Atsumi, Taichi Hayashi, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Rheumatology|January 17, 2014
Comparison of phenotype and outcome in microscopic polyangiitis between Europe and JapanShunsuke Furuta, Afzal N Chaudhry, Yoshitomo Hamano, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|June 19, 2022
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccinesMariko Mouri, Mitsuru Imamura, Shotaro Suzuki, et al.
Modern Rheumatology|December 1, 2021
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitisTakahiko Sugihara, Yoshikazu Nakaoka, Haruhito A Uchida, et al.
Modern Rheumatology|June 9, 2025
Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two yearsKenji Nagasaka, Koichi Amano, Hiroko Nagafuchi, et al.
Modern Rheumatology|December 8, 2022
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 monthsKenji Nagasaka, Koichi Amano, Hiroaki Dobashi, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 11, 2024
Clinical Characteristics and Treatment Outcomes of Patients With Newly Diagnosed Takayasu Arteritis in Japan During the First 2 Years of Treatment - A Nationwide Retrospective Cohort StudyHaruhito A Uchida, Yoshikazu Nakaoka, Takahiko Sugihara, et al.
Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.
Modern Rheumatology|September 20, 2011
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV studyShoichi Ozaki, Tatsuya Atsumi, Taichi Hayashi, et al.
Pageof 4